Feedback / Questions
Siliq (brodalumab) - Bausch Health, Leo Pharma, Kyowa Hakko Kirin
Brodalumab: Regulatory decision in Asia for psoriasis in 2020
(Kyowa Hakko Kirin Pharma)
-
Aug 2, 2019 -
Q2 2019 Results
Non-US regulatory
https://ir.kyowakirin.com/en/library/earnings.html
Aug 2, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious